DGX 241018 150.00P (DGX241018P150000) Stock Options, News & Quotes

US OptionsDetailed Quotes

DGX241018P150000

Watchlist

0.64
-1.11-63.43%

15min DelayClose Oct 18 16:00 ET

1.50High0.20Low

Intraday

5D
Daily

News

UBS Maintains Quest Diagnostics(DGX.US) With Hold Rating, Raises Target Price to $165
Moomoo NewsOct 18 04:31 ET · Ratings
Express News | Quest Diagnostics Inc : UBS Raises Target Price to $165 From $151
ReutersOct 17 10:19 ET
Earnings Preview: DGX to Report Financial Results Pre-market on October 22
Moomoo NewsOct 16 21:00 ET
Barclays Maintains Quest Diagnostics(DGX.US) With Hold Rating, Maintains Target Price $154
Moomoo NewsOct 16 05:33 ET · Ratings
Quest Diagnostics Introduces Specimen Self-Collection for Common Genital Tract Infection Testing at Nationwide Network of Patient Service Centers
PR NewswireOct 15 08:04 ET
Asia Cervical Cancer Screening Market Forecast Report 2024-2032, Featuring Profiles of Abbott Laboratories, Hologic, Becton, Siemens, Roche Diagnostics, Quest Diagnostics and Cardinal Health
Yahoo FinanceOct 15 05:26 ET

Comments

ForeverBean

Jun 1 04:19

$Quest Diagnostics (DGX.US)$ PathAI + Invigorate + stable finance + qualified management team + decent PE.
Will it dominate pathology and cancer diagnosis with AI in the future? Worth noting.

Moomoo AI

Jan 11 05:10

Quest Diagnostics' consistent ROCE and increased capital employed over the past five years suggest steady reinvestment at good returns. This trend, reflected in the stock's strong performance, is expected to continue.

Returns On Capital At Quest Diagnostics (NYSE:DGX) Have Stalled

Moomoo AI

Jan 8 08:01

The acquisition aligns with Quest's strategy to grow through accretive outreach laboratory acquisitions and expands its ability to serve providers and patients in Ohio and Pennsylvania.

Press Release: Quest Diagnostics Acquires Select Assets of Outreach Lab Services Business of Steward Health Care System

Moomoo AI

Dec 20, 2023 06:39

The CEO of Quest Diagnostics, Jim Davis, believes Yuri Fesko's deep medical expertise and patient-care advocacy will greatly contribute to the company's strategic decisions. His appointment especially bolsters Quest's efforts to improve customer experiences via diagnostic innovations.

Press Release: Quest Diagnostics Names Yuri A. Fesko, M.D., Senior Vice President and Chief Medical Officer

Moomoo AI

Dec 6, 2023 04:43

Quest Diagnostics shows favorable metrics with robust reinvestment strategies. Significant earnings growth and an anticipated rise in future ROE, despite a higher payout ratio, hint at other growth factors.

Quest Diagnostics Incorporated's (NYSE:DGX) Stock Has Fared Decently: Is the Market Following Strong Financials?